Skip Nav Destination

Hemifacial myohyperplasia is due to somatic muscular PIK3CA gain-of-function mutations and responds to pharmacological inhibition

J Exp Med (2023) 220 (11): e20230926.
Currently there are no citedby results. Try again later.